---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-088380"
form_type: "8-K"
ticker: "LIMN"
cik: "0001971387"
company_name: "Liminatus Pharma, Inc."
filed_at: "2026-07-30T01:49:15+00:00"
generated_at: "2026-07-30T10:05:05.066409+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Liminatus Pharma believes it meets Nasdaq equity minimum after InnocsAI merger

## Summary
- Company believes stockholders' equity now exceeds $2.5 million following merger with InnocsAI LLC.
- Awaiting Nasdaq compliance determination; Nasdaq will continue to monitor compliance.
- If next periodic report does not show compliance, Company may face future delisting.
- Merger with InnocsAI LLC previously announced; no further deal terms disclosed.

## SEC filing metadata
- accession: 0001104659-26-088380
- form_type: 8-K
- ticker: LIMN
- cik: 0001971387
- company_name: Liminatus Pharma, Inc.
- filed_at: 2026-07-30T01:49:15+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971387/000110465926088380/0001104659-26-088380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926088380/tm2621658d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-088380
- JSON: https://secwatch.observer/filing/0001104659-26-088380.json
- Plain text: https://secwatch.observer/filing/0001104659-26-088380.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.